Admissions at Datta Meghe College of Pharmacy for the 2026 session use different routes for UG and PG programmes. B.Pharm and D.Pharm use DMIHER’s own All India Pharmacy Entrance Test (AIPET) alongside MHT CET and NEET UG. M.Pharm uses GPAT via MAH CAP counselling.
| Event | Date |
|---|---|
| GPAT 2026 Exam | March 7, 2026 |
| GPAT 2026 Result Declared | April 7, 2026 |
| MAH CAP (M.Pharm) Counselling | Ongoing (2026) |
| DMIHER-AIPET (B.Pharm and D.Pharm) | Ongoing - visit dmiher.edu.in for current dates |
| Pharm.D Admissions | Institute-level counselling - ongoing |
The table below lists the qualifying exams accepted for each programme at DMCOP Wardha.
| Course | Exam Accepted |
|---|---|
| D.Pharm | DMIHER-AIPET / MHT CET / NEET UG |
| B.Pharm | DMIHER-AIPET / MHT CET / NEET UG |
| B.Pharm Lateral Entry | D.Pharm merit-based (lateral route) |
| Pharm.D | DMIHER-AIPET / MHT CET / NEET UG |
| M.Pharm | GPAT (via MAH CAP counselling) |
| Ph.D. | UGC-NET / GPAT / DMIHER Research Entrance Test |
D.Pharm and B.Pharm Admission
Undergraduate pharmacy admissions at DMCOP Wardha go through DMIHER’s own All India Pharmacy Entrance Test (AIPET). Candidates can also use valid MHT CET or NEET UG scores. Eligibility and selection stages:
- Completed 10+2 with Physics, Chemistry, and Biology or Mathematics
- Minimum 45% aggregate in qualifying subjects (40% for reserved category candidates from Maharashtra)
- Minimum age 17 years on or before December 31 of the admission year
- Stage 1: Register on dmiher.edu.in and appear for AIPET or submit MHT CET or NEET UG score
- Stage 2: Merit-based shortlisting and institute-level counselling
- Stage 3: Document verification and admission confirmation
B.Pharm 2026 sanctioned intake is 100 seats. D.Pharm intake is 60 seats. NRI quota seats are available across all UG programmes.
Pharm.D Admission
Pharm.D at DMCOP is a six-year programme (five years academic plus one year internship). Admission uses DMIHER-AIPET or MHT CET or NEET UG merit. Sanctioned intake is 30 seats. The programme is approved by PCI and leads to a doctorate-level clinical pharmacy qualification.
M.Pharm Admission
M.Pharm admissions use valid GPAT scores, routed through MAH CAP (Maharashtra Common Admission Process) counselling. Eligibility requires B.Pharm with a minimum 55% aggregate. Candidates without GPAT may apply through institute-level counselling based on B.Pharm merit, subject to PCI norms. GPAT 2026 results were declared on April 7, 2026 and MAH CAP counselling is ongoing.




